Please view our affiliate disclosure. Trading involves risk which may result in the loss of capital. The Injective Protocol (INJ) seeks to tackle a variety of issues that continue to cause developers ...

To learn more about Azstarys, see this Azstarys overview. Your doctor likely will start your treatment with an Azstarys dosage of 39.2 mg/7.8 mg once per day. They may increase the dosage after 1 ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Beacon Roofing (NASDAQ:BECN) adopted a poison pill after QXO Inc. on Monday announced an $11 billion hostile bid for the building products company. The poison pill kicks in when a person or group ...

On Jan. 15, QXO — the building materials distribution platform started in late 2023 by Brad Jacobs — confirmed its November offer to buy Beacon Roofing Supply. Beacon verified, later that day, that ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action on behalf of purchasers and acquirers of securities of ESSA Pharma Inc.

(NYSE: QXO) today announced that it is commencing an all-cash tender offer to acquire all outstanding shares of Beacon Roofing Supply, Inc. (Nasdaq: BECN) for $124.25 per share. This price implies ...

The dosage for bupropion varies depending on the condition it’s being used to treat and the form of the drug you’re prescribed. Your doctor will prescribe the dosage and form that’s best for ...

Reviewers have tested some of the products below and may have received some products from the manufacturers for free. All opinions are the reviewers’ own. These full-spectrum gummies are ...

The country's pharma lobby groups have been seeking a two-year extension to the deadline, saying that much time is needed for improving infrastructure, increasing manpower and training. The lobby ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the prescription ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion in a new settlement to lawsuits over the toll of the powerful prescription ...